Exclusive: Two GOP lawmakers call on FDA to increase scrutiny of Chinese trial data following deaths

GOP Reps. Moolenaar & Cline urge FDA's Diamantas to reject Chinese clinical trial data unless sites are audited annually, citing patient safety risks & 3 deaths.

Raccontata daendpoints.news